Specialties & Research
Pediatric Surgery Specialties
- Strabismus surgery (lazy eye and/or double vision)
- Nasolacrimal duct surgery (for watery eyes)
- Ptosis surgery (droopy eyelid)
- Chalazion and eyelid lesions
- Orbital fracture repair
- Capillary Hemangioma
- Enucleation
- Surgery for abnormal head posture cause by strabismus or nystagmus
Adult Surgery Specialties
- Eyelid and Laser Surgery
- Upper Eyelid Lift
- Brow Lift
- Lower Eyelid Lift
- Cortex Fraction C02 and Erbium Laser Facial Resurfacing
- Ectropion (outward turning eyelid)
- Entropion (in-turning eyelid)
- Skin cancer removal and reconstructive eyelid surgery
- Dacryocystorhinostomy (DCR) for tearing
20+
Years In Practice
10,000+
SURGICAL PROCEDURES
50+
RESEARCH PAPERS AND PROPOSALS
50,000+
PATIENTS SEEN
Completed Studies
- Pediatric Eye Disease Investigator Group C02 Pediatric cataract surgery registry
- Pediatric Eye Disease Investigator Group CITS Convergence insufficiency treatment study
- Pediatric Eye Disease Investigator Group IXT1 Randomized trial of bilateral lateral rectus recession versus unilateral recess-resect for intermittent exotropia
- Pediatric Eye Disease Investigator Group IXT2 Randomized clinical trial of observation versus occlusion therapy for intermittent exotropia
- Pediatric Eye Disease Investigator Group IXT3 A pilot randomization clinical trial of overminus therapy for intermittent exotropia
- Pediatric Eye Disease Investigator Group E02 Esotropia treatment with Botox data collection
- GoCheck Prospective Evaluation of mobile phone photography application as a vision screening tool in children
- Pediatric Eye Disease Investigator Group ATS18 Study of binocular computer activities for treatment of amblyopia
- Pediatric Eye Disease Investigator Group protocol HTS1 Glasses vs observation for moderate hyperopia in young children
- Pediatric Eye Disease Investigator Group protocol ATS17 A Randomized trial of Levodopa as treatment for residual amblyopia
- Pediatric Eye Disease Investigator Group protocol CITS Convergence insufficiency treatment study
- Pediatric Eye Disease Investigator Group protocol HTS1 Glasses vs observation for moderate hyperopia in young children
- Pediatric Eye Disease Investigator Group protocol A16 Augmenting Atropine Treatment for Amblyopia
- Pediatric Eye Disease Investigator Group protocol A15 – Increasing Patching for Amblyopia
- Pediatric Eye Disease Investigator Group protocol A14 A pilot study to evaluate Levodopa as treatment for residual amblyopia in 8 to 17 year olds
- Pediatric Eye Disease Investigator Group protocol A13 An observational study of optical correction for strabismic amblyopia in children 3 to <7 years old
- Pediatric Eye Disease Investigator Group protocol A12 A Randomized Trial Comparing Patching with Active Vision Therapy to Patching with Control Vision Therapy for Amblyopia in Children 7 to < 13 Years Old
- Pediatric Eye Disease Investigator Group protocol A11 A Randomized Trial to Evaluate 8 Hours of Daily Patching Plus Daily Atropine for Residual Amblyopia in Children 3 to <8 Years Old
- Pediatric Eye Disease Investigator Group protocol A10 A Randomized Trial of Full-time Bangerter Filters versus Part-time Daily Patching for the Treatment of Moderate Amblyopia in Children
- Pediatric Eye Disease Investigator Group protocol ATS9 A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to <13 Year Olds
- Pediatric Eye Disease Investigator Group protocol ATS8 A Randomized Trial Comparing Atropine to Atropine Plus a Reduced-Plus Lens for the Sound Eye as Treatments for Amblyopia in Children 3 to <7
- Pediatric Eye Disease Investigator Group protocol ATS7 Bilateral Refractive Amblyopia Treatment Study
- Pediatric Eye Disease Investigator Group protocol ATS6 A Randomized Trial to Compare Near Versus Distance Activities While Patching for Amblyopia
- Pediatric Eye Disease Investigator Group protocol ATS5 Treatment of Anisometropic Amblyopia in Children with Refractive Correction
- Pediatric Eye Disease Investigator Group protocol ATS4 A Randomized Trial of Atropine Regimens for Treatment of Moderate Amblyopia in Children
- Pediatric Eye Disease Investigator Group protocol ATS3 A prospective, pilot study of treatment of amblyopia in children 10 to <18 years old
- Pediatric Eye Disease Investigator Group protocol ATS2A A randomized trial comparing part-time vs. full-time patching for severe amblyopia
- Pediatric Eye Disease Investigator Group protocol ATS2B A randomized trial comparing part-time versus minimal-time patching for moderate amblyopia
- Pediatric Eye Disease Investigator Group protocol ATS2C Risk of amblyopia recurrence after cessation of treatment
- Pediatric Eye Disease Investigator Group protocol ATS1 A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children
- Pediatric Eye Disease Investigator Group protocol NLD 1 A Prospective Study of Primary Surgical Treatment of Nasolacrimal Duct Obstruction in Children Less Than Four Years Old
- Pediatric Eye Disease Investigator Group protocol NLD2 A Prospective Study of Surgical Procedures for the Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 years old
- Pediatric Eye Disease Investigator Group protocol NLD3 A Randomized Trial Comparing Immediate Probing in an Office Setting with Deferred Probing in a Facility Setting for Treatment of Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old
- Pediatric Eye Disease Investigator Group protocol ETS1 An Observational Study of Infantile, Acquired Non-accommodative, and Acquired Partially-accommodative Esotropia
- Pediatric Eye Disease Investigator Group protocol CCT A Prospective Study of Central Corneal Thickness in Children Less than 18 Years old
- Pediatric Eye Disease Investigator Group protocol COMET2 A randomized trial of the effect of progressive addition lenses versus single vision lenses on low myopia associated with large accommodative lags and near esophoria in children
- Pediatric Eye Disease Investigator Group protocol X01 Correction of Refractive Error for Amblyopia Study
- Bausch & Lomb A randomized, double-masked, active-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of topical besifloxacin ophthalmic suspension, 0.6% compared with gatifloxacin, 0.3% ophthalmic solution for the treatment of presumed bacterial conjunctivitis in subjects from birth to 31 days of age
- Bausch & Lomb A Clinical and Efficacy Evaluation of Zylet (Ioteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) compared to Lotemax (Ioteprednol etabonate ophthalmic suspension 0.5%), Tobramycin Ophthalmic Solution USP, 0.3%, and the Vehicle of Zylet for the Treatment of Blepharoconjunctivitis in Pediatric Subjects
- Bausch & Lomb Study #459 A Safety and Efficacy Study of Zylet® (Ioteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) Compared to Vehicle in the Management of Lid Inflammation in Pediatric Subjects
- Alcon Evaluation of ESBa105 in the persistent relief of ocular discomfort in patients with severe dry eye
- Inspire A multi-center, parallel-group, double-masked, randomized, placebo-controlled study of the effects of diquafosol tetrasodium ophthalmic solution, 2% in subjects with dry eye disease and a central corneal staining score of 3 (NEI Scale)
- Alcon A Randomize, Double-Masked and Efficacy Study of FID #109980 Compared to FID #110656 in the Treatment of Dry Eye
- Lexitas Dry Eye Study A multi-center, double-masked, randomized, controlled, efficacy and safety study of EBI-005 5 mg/mL topical ophthalmic solution versus vehicle control in subjets with moderate to severe dry eye disease
- TearScience LF-001 Randomized Clinical Trial for Treatment of Meibomian Gland Dysfunction and Evaporation Dry Eye
- Bausch & Lomb A study to evaluate the clinical and microbial efficacy of Besifloxacin Ophthalmic Suspension, 0.6% BID compared to vehicle in the treatment of bacterial conjunctivitis
- Bausch & Lomb Study A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vigamox in the Treatment of Bacterial Conjunctivitis
- Eli Lilly Study of the possible association between the use of PDE5 inhibitors and the risk of acute nonarteritic anterior ischemic optic neuropathy (NAION)
- Pfizer study A1481259 Case-Crossover Study of PDE5 Inhibitor Exposure as a Potential “Trigger Factor” for Acute NAION
- Bausch & Lomb A randomized, multicenter, double-masked, parallel-group, clinical safety and efficacy evaluation of loteprednol etabonate ophthalmic gel, 0.5% versus vehicle for the treatment of inflammation and pain following cataract surgery
- Bausch & Lomb A phase 3, multi-center, double-masked, vehicle-controlled, randomized, parallel-group study to assess loteprednol etabonate ophthalmic gel, 0.38% versus vehicle gel for the treatment of ocular inflammation and pain following cataract surgery
- Inspire Study Phase IV. A Multi-Center, Open-Label, Registry of Epinastine HCl Ophthalmic Solution, 0.05% (Elestat) in Subjects with History and Current Complaint of Ocular Allergy Symptom
- A clinical evaluation of Juvederm Ultra Injectable Gel for the correction of moderate to severe facial wrinkles and folds ( Silbert)
- Study utilizing the platelet factor 4 – fluorescein method for examination of endothelial cell surface and platelet surface proteoglycans
- Study Developing a platelet factor 4 – fluorescein probe and applied it to the examination of the content and distribution of cell surface proteoglycans in cultures of several types of cells
- Study on organic synthesis of histochemical dyes
See the difference nice makes with Conestoga Eye
Visit Your Trusted Pediatric Ophthalmologist
Thank you for subscribing!
You will receive important news and updates from our practice directly to your inbox.
Thanks!